Prelude Therapeutics PRLD
NASDAQ PRLD
$3.63 +0.03 (+0.83%)
At close: Oct 23, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Net Preferred Shares Issued and Repurchased (2020)

Updated

Analysis

Prelude Therapeutics (PRLD) Net Preferred Shares Issued and Repurchased (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Prelude Therapeutics 289.69 Mn -307.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 49.83 Mn
API Access

Prelude Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=PRLD&period=max&api_key=YOUR_API_KEY